Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
Arthritis Res Ther. 2020 Jun 26;22(1):162.
doi: 10.1186/s13075-020-02256-2.
1 Department of Infectious Diseases, Central Hospital Kristianstad, J A Hedlunds väg 5, SE-291 85, Kristianstad, Sweden. [email protected].
2 Department of Clinical Sciences Lund, Section for Rheumatology, Lund University, Lund and Skåne University Hospital, Lund, Sweden. [email protected].
3 Department of Clinical Sciences Lund, Section of Infectious Diseases, Lund University and Skåne University Hospital, Lund, Sweden.
4 Department of Infectious Diseases, Central Hospital Kristianstad, J A Hedlunds väg 5, SE-291 85, Kristianstad, Sweden.
5 Department of Clinical Sciences Lund, Section for Rheumatology, Lund University, Lund and Skåne University Hospital, Lund, Sweden.
6 Department of Microbiological Diagnostics & Virology, Statens Serum Institut, Copenhagen, Denmark.
7 Department of Laboratory Medicine, Section of Microbiology, Immunology and Glycobiology, Lund, University, Lund and Clinical Immunology and Transfusion Medicine, Region Skåne, Lund, Sweden.